Pharmacokinetics of muscarinic cholinergic drugs as determined by ex vivo (3H)-oxotremorine-M binding
- 1 July 1990
- journal article
- research article
- Published by Elsevier in Journal of Pharmacological Methods
- Vol. 23 (4) , 285-296
- https://doi.org/10.1016/0160-5402(90)90057-r
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Pharmacokinetics of buspirone as determined by ex vivo (3H)-DPAT bindingLife Sciences, 1988
- MUSCARINIC ACTIONS OF AN N-METHYL-N-2-BROMOETHYLAMINO ANALOG OF OXOTREMORINE (BR 401) IN THE MOUSE1987
- Onset and duration of action of benzodiazepines as determined by inhibition of (3H)‐flunitrazepam bindingDrug Development Research, 1987
- Behavioural and pharmacological characterization of the mouth movements induced by muscarinic agonists in the ratPsychopharmacology, 1986
- Selective muscarinic receptor antagonistsTrends in Pharmacological Sciences, 1984
- Interaction of triazolobenzodiazepines with benzodiazepine receptorsJournal of Pharmacy and Pharmacology, 1983
- A pharmacokinetic/pharmacodynamic/receptor binding model to predict the onset and duration of pharmacological activity of the benzodiazepinesProgress in Neuro-Psychopharmacology and Biological Psychiatry, 1983
- Effect of oxotremorine on endogenous acetylcholine and on uptake and biotransformation of radioactive choline in discrete regions of mouse brain in vivoBiochemical Pharmacology, 1976
- The identification of an active metabolite of tremorineBiochemical and Biophysical Research Communications, 1961